$21.00
0.231.11%
At Close: -
$21.00
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Contineum Therapeutics
CTNMNASDAQ
Contineum Therapeutics (CTNM) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestContineum Therapeutics (NASDAQ:CTNM) Stock Quotes, Forecast and News Summary
Contineum Therapeutics Stock (NASDAQ: CTNM) stock price, news, charts, stock research, profile.
| Open | $20.77 |
| Close | $21.00 |
| Volume / Avg. | 74.14K / 88.57K |
| Day Range | 20.40 - 21.43 |
| 52 Wk Range | 13.27 - 22.00 |
| Market Cap | $540.19M |
| P/E Ratio | 29.71 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | - |
| Days to Cover | 2.8 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Contineum Therapeutics Inc.
Sector
Health Care
Industry
Pharmaceuticals
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Contineum Therapeutics (CTNM) stock?
You can purchase shares of Contineum Therapeutics (NASDAQ:CTNM) through any online brokerage.
Who are Contineum Therapeutics (CTNM) competitors?
Other companies in Contineum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the target price for Contineum Therapeutics (CTNM) stock?
There is no analysis for Contineum Therapeutics.
What is the forecast for Contineum Therapeutics (CTNM) stock?
Contineum Therapeutics has a consensus price target of $28.00.
Current stock price for Contineum Therapeutics (CTNM)?
The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $21 last updated July 15, 2024 at 4:00 PM EDT.
Does Contineum Therapeutics (CTNM) pay a dividend?
There are no upcoming dividends for Contineum Therapeutics.
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics’s Q3 earnings are confirmed for Friday, August 16, 2024.
Is Contineum Therapeutics (CTNM) going to split?
There is no upcoming split for Contineum Therapeutics.
What sector and industry does Contineum Therapeutics (CTNM) operate in?
Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.